THE COMPARATIVE EFFECTIVENESS OF CYCLING TUMOURNECROSIS FACTOR INHIBITOR (TNFI) VERSUS SWAPPING TO A NONTNFI ON PATIENT-REPORTED FUNCTIONAL ABILITY OF PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Lopez-Oliva, M. A. [1 ]
Matusevich, A. [1 ]
Cantor, S. B. [2 ]
Pratt, G. [3 ]
Suarez-Almazor, M. E. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Gen Internal Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Hlth Serv Res, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Res Med Lib, Houston, TX 77030 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.6989
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0298
引用
收藏
页码：196 / 196
页数：1
相关论文
共 50 条
  • [1] The Comparative Effectiveness of Cycling Tumor Necrosis Factor Inhibitor (TNFi) Versus Swapping to a Nontnfi on Patient-Reported Functional Ability of Patients with Rheumatoid Arthritis
    Lopez-Olivo, Maria A.
    Matusevich, Aliza
    Cantor, Scott B.
    Pratt, Gregory
    Suarez-Almazor, Maria
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [2] Physician- and Patient-reported Effectiveness Are Similar for Tofacitinib and TNFi in Rheumatoid Arthritis: Data From a Rheumatoid Arthritis Registry
    Movahedi, Mohammad
    Cesta, Angela
    Li, Xiyuing
    Keystone, Edward C.
    Bombardier, Claire
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (05) : 447 - 453
  • [3] A comparative study of patient-reported functional outcomes in acute rheumatoid arthritis
    Zochling, Jane
    Stucki, Gerold
    Grill, Eva
    Braun, Juergen
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (01) : 64 - 69
  • [4] REAL-WORLD GOLIMUMAB EFFECTIVENESS AND IMPACT ON PATIENT-REPORTED OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS OR AXIAL SPONDYLARTHRITIS AND A TREATMENT FAILURE TO PREVIOUS TNFI INHIBITOR THERAPY
    Georgiadis, A.
    Theodoridou, A.
    Vounotrypidis, P.
    Zisopoulos, D.
    Kallitsakis, I
    Kandyli, A.
    Migkos, M.
    Bournazos, I
    Sidiropoulos, P.
    Efstathiou, M.
    Athanassiou, P.
    Haratsis, I
    Petrikkou, E.
    Vassilopoulos, D.
    VALUE IN HEALTH, 2019, 22 : S433 - S433
  • [5] Treatment Sequences After Discontinuing a Tumor Necrosis Factor Inhibitor in Patients With Rheumatoid Arthritis: A Comparison of Cycling Versus Swapping Strategies
    Matusevich, Aliza R. Karpes
    Duan, Zhigang
    Zhao, Hui
    Lal, Lincy S.
    Chan, Wenyaw
    Suarez-Almazor, Maria E.
    Giordano, Sharon H.
    Swint, J. Michael
    Lopez-Olivo, Maria A.
    ARTHRITIS CARE & RESEARCH, 2021, 73 (10) : 1461 - 1469
  • [6] Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registry
    Leslie R. Harrold
    George W. Reed
    Daniel H. Solomon
    Jeffrey R. Curtis
    Mei Liu
    Jeffrey D. Greenberg
    Joel M. Kremer
    Arthritis Research & Therapy, 18
  • [7] Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registry
    Harrold, Leslie R.
    Reed, George W.
    Solomon, Daniel H.
    Curtis, Jeffrey R.
    Liu, Mei
    Greenberg, Jeffrey D.
    Kremer, Joel M.
    ARTHRITIS RESEARCH & THERAPY, 2016, 18
  • [8] The Comparative Effectiveness of First-Line Tumor Necrosis Factor Inhibitor (TNFi) Compared with Non-TNFi Agents in Patients with Rheumatoid Arthritis: Results from the Corrona Registry
    Pappas, Dimitrios A.
    St John, Gregory
    Etzel, Carol J.
    Fiore, Stefano
    Blachley, Taylor
    Kimura, Toshio
    Punekar, Rajeshwari
    Emeanuru, Kelechi
    Boklage, Susan
    Kremer, Joel
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [9] COMPARATIVE EFFECTIVENESS OF ABATACEPT VERSUS TNFI IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO ARE CCP plus IN THE UNITED STATES CORRONA REGISTRY
    Harrold, L.
    Litman, H.
    Connolly, S.
    Alemao, E.
    Price, K.
    Kelly, S.
    Rebell, S.
    Hua, W.
    Kremer, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1192 - 1192
  • [10] COMPARATIVE EFFECTIVENESS OF RITUXIMAB VERSUS SUBSEQUENT ANTI-TUMOR NECROSIS FACTOR IN CUMULATIVE PREDNISONE EXPOSURE IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH PRIOR EXPOSURE TO TNFI
    Harrold, L.
    Reed, G.
    Magner, R.
    Shewade, A.
    John, A.
    Greenberg, J.
    Kremer, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 508 - 508
12345